AJMC Contributor

A new generation of chimeric antigen receptor T-cell therapy has shown promising efficacy and safety in a small study of heavily pretreated patients with chronic lymphocytic leukemia (CLL).1  Results of the early-/mid-stage study, published in Leukemia, found encouraging response rates […]

Researchers of a new study are underscoring the value of automated measures for determining the presence of interventricular septal (IVS) flattening in patients with pulmonary hypertension (PH).1 Findings from the retrospective study suggest that both visual and quantitative measures have

Through whole transcriptome and whole genome sequencing, researchers of a new study are suggesting a certain gene expression be considered the defining feature of acute myeloid leukemia (AML) with t(7;12)(q36;p13).1 Recently recognized by the World Health Organization (WHO), AML with

Data from a new analysis of a range of treatments used for myasthenia gravis (MG) are providing insight into the most effective options for the disease, according to the researchers of the analysis.1 The network meta-analysis included data from 1657

Researchers of a new paper have detailed updated surveillance recommendations for children with certain germline gene variants associated with an increased risk of myelodysplastic syndromes (MDS) and other hematopoietic malignancies (HMs).1 The recommendations for surveillance account for newly identified hematopoietic

Receiving a stem cell transplant after achieving complete response (CR) may yield better outcomes than chemotherapy for patients with acute myeloid leukemia (AML), suggest findings from a meta-analysis of randomized controlled trials.1 The analysis, published in Annals of Hematology, found

A certain biomarker measured at any point in time may help predict worsening disability among patients with MS receiving specific treatments. Image Credit: sebastianlaulitzki – stock.adobe.com New study findings provide indications that a certain biomarker measured at any point in

Getting a tattoo may increase the risk of certain types of non-Hodgkin lymphoma (NHL), suggested by findings from a small case-control study published in Cancer Medicine.1 New evidence suggest a slight connection between receiving a tattoo and elevated cancer risks

Amidst efforts to identify reliable biomarkers in multiple sclerosis (MS), researchers of a new paper have outlined the promise, and drawbacks, of established and emerging biomarkers in the disease.1  As with other disease states, biomarkers that can provide value across

Details from the phase 3 trial assessing delandistrogene moxeparvovec (Elevidys) for managing Duchenne muscular dystrophy (DMD) have been published, months after Sarepta Therapeutics announced that the drug failed to meet the study’s primary endpoint.1,2 Put up against placebo in the